Review
Accepted on 19 Nov 2024
Application of nanotechnology in the treatment of hepatocellular carcinoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1438819
Type at least 3 characters
24,507 articles
Articles
Review
Accepted on 19 Nov 2024
Targeting cuproptosis with nano material: New way to enhancing the efficacy of immunotherapy in colorectal cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1451067
Review
Accepted on 19 Nov 2024
Pediatric Flecainide Pharmacogenomics: A Roadmap to Deliver Precision Based Care to Pediatrics Arrhythmias
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1477485
Original Research
Accepted on 19 Nov 2024
6-Hydroxyflavanone Treats Anxiety and Chemotherapy-Induced Neuropathy in Sprague Dawley Rats
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1486918
Original Research
Accepted on 19 Nov 2024
Shenshuaikang enema restores the intestinal barrier and microbiotagut-kidney axis balance to alleviate chronic kidney disease via NF-kB pathway
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1453668
Systematic Review
Accepted on 19 Nov 2024
Effect of Icariin on Ovarian Cancer: A Combined Network Pharmacology and Meta-Analysis of In Vitro Studies Approach
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1418111
Original Research
Accepted on 19 Nov 2024
Menisoxoisoaporphine A, a novel oxoisoaporphine alkaloid from Menispermi Rhizoma, inhibits inflammation by targeting PDE4B
in Ethnopharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1505116
Original Research
Accepted on 19 Nov 2024
Kidney Outcomes Associated with SGLT2 Inhibitors Compared to Other Glucose-Lowering drugs: A Real-world Study from China
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1468435
Original Research
Accepted on 19 Nov 2024
Drug-Induced Retinal Vein Occlusion: A Disproportionality Analysis From the FDA Adverse Event Reporting System (2004-2023)
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1480269
Review
Accepted on 19 Nov 2024
Plant protein-derived anti-breast cancer peptides: sources, therapeutic approaches, mechanisms, and nanoparticle design
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1468977
Original Research
Published on 19 Nov 2024
Dipeptide alanine-glutamine ameliorates retinal neurodegeneration in an STZ-induced rat model
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1490443
- 173 views
Original Research
Published on 19 Nov 2024
Mechanism of Valeriana officinalis L. extract improving atherosclerosis by regulating PGC-1α/Sirt3/Epac1 pathway
in Ethnopharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1483518
- 240 views
Original Research
Published on 19 Nov 2024
Targeting autophagy: polydatin’s role in inducing cell death in AML
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1470217
- 103 views
Original Research
Published on 19 Nov 2024
Preliminary investigation of the in vitro anti-Helicobacter pylori activity of Triphala
in Ethnopharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1438193
- 229 views
Systematic Review
Published on 19 Nov 2024
Efficacy and safety of lebrikizumab for the treatment of moderate-to-severe atopic dermatitis: a systematic review and meta-analysis
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1429709
- 197 views
Original Research
Published on 19 Nov 2024
Clinical and non-clinical aspects of reimbursement policy for orphan drugs in selected European countries
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1498386
- 193 views